Skip to main content Start main content

What is Light Therapy?

Light therapy is a treatment that uses different types of light to help treat eye problems. It’s a safe and non-invasive way to improve eye health, reduce inflammation, and promote healing.

 

How Does Light Therapy Work?

Light therapy uses special wavelengths of light to:

  1. Help control eye growth (especially in children).
  2. Speed up healing of damaged eye cells.
  3. Reduce swelling and irritation in the eyes.

     

    Conditions Treated with Light Therapy

    Here’s how light therapy can help with common eye conditions:

  1. Myopia (Nearsightedness)Red light therapy helps slow down eye growth, which can stop myopia from getting worse in children and teens.
  2. Age-Related Macular Degeneration (AMD)Light therapy helps treat abnormal blood vessels in the retina, slowing down vision loss in older adults.
  3. Dry Eye SyndromeLight therapy improves tear production and reduces irritation, giving relief from dryness and redness.
  4. Diabetic Eye DiseasesLight therapy can help reduce swelling and improve blood flow to protect the retina in people with diabetes.
  5. Retinal DiseasesLight therapy helps slow down damage to the retina in conditions like Retinitis Pigmentosa.

 

What to Expect

 

  • Non-Invasive: Light therapy is painless and doesn’t require surgery.
  • Quick Sessions: Treatment usually takes 15-30 minutes.
  • No Recovery Time: You can go back to your normal activities right after the session.

 

Is Light Therapy Right for Me?

Talk to your doctor to see if light therapy could help your eye condition. They’ll decide the best treatment plan for you.

 

Conclusion

Light therapy is a safe and effective treatment for many eye problems, from nearsightedness to dry eyes and more. It’s a simple option to help protect and improve your vision.

 

References

 

1. Jiang Y, Zhu Z, Tan X, Kong X, Zhong H, Zhang J, Xiong R, Yuan Y, Zeng J, Morgan IG, He M. Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children: A Multicenter Randomized Controlled Trial. Ophthalmology. 2022 May;129(5):509-519. doi: 10.1016/j.ophtha.2021.11.023. Epub 2021 Dec 1. PMID: 34863776.

2. Xiong R, Zhu Z, Jiang Y, Kong X, Zhang J, Wang W, Kiburg K, Yuan Y, Chen Y, Zhang S, Xuan M, Zeng J, Morgan IG, He M. Sustained and rebound effect of repeated low-level red-light therapy on myopia control: A 2-year post-trial follow-up study. Clin Exp Ophthalmol. 2022 Dec;50(9):1013-1024. doi: 10.1111/ceo.14149. Epub 2022 Sep 7. PMID: 36054314; PMCID: PMC10086781.

3. Zhu Q, Cao X, Zhang Y, Zhou Y, Zhang J, Zhang X, Zhu Y, Xue L. Repeated Low-Level Red-Light Therapy for Controlling Onset and Progression of Myopia-a Review. Int J Med Sci. 2023 Sep 4;20(10):1363-1376. doi: 10.7150/ijms.85746. PMID: 37786442; PMCID: PMC10542022.

4. Boyer D, Hu A, Warrow D, Xavier S, Gonzalez V, Lad E, Rosen RB, Do D, Schneiderman T, Ho A, Munk MR, Jaffe G, Tedford SE, Croissant CL, Walker M, Rückert R, Tedford CE. LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System. Retina. 2024 Mar 1;44(3):487-497. doi: 10.1097/IAE.0000000000003980. PMID: 37972955; PMCID: PMC10885856.

5. Markoulli M, Chandramohan N, Papas EB. Photobiomodulation (low-level light therapy) and dry eye disease. Clin Exp Optom. 2021 Jul;104(5):561-566. doi: 10.1080/08164622.2021.1878866. Epub 2021 Feb 27. PMID: 33689636.

 

 

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here